Final survival analysis of the phase II Study of weekly paclitaxel plus bevacizumab in previously treated non-Sq NSCLC

Authors :: Yasuto Ueda
Tadashi Igishi
Hirokazu Touge
Takashi Sumikawa
Kenichi Takeda
Eiji Shimizu
Naoki Kinoshita
Hirofumi Nakazaki
Haruhiko Makino
Masahiro Kodani
Source :: Annals of Oncology. 26:vii125
Publication Year :: 2015
Publisher :: Elsevier BV, 2015.

Subjects :: Oncology
medicine.medical_specialty
Bevacizumab
business.industry
Phases of clinical research
Weekly paclitaxel
Hematology
chemistry.chemical_compound
Paclitaxel
chemistry
Internal medicine
Medicine
business
Previously treated
Survival analysis
medicine.drug

Full Text Access

Tools